RxDoctor Payments Data

Nirali Doshi, MD

Pain Medicine · Joliet, ILNPI 1659664969

Payments from drug & device makers

$1,973in general payments, 2019–2025

Across 82 payments — averaging $24.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$865
  • Abbott$337
  • Pfizer$182
  • Merck$93
  • Collegium Pharmaceutical, Inc.$85
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
  • plus $352 from 13 others

What the payments were for

  • Food & beverage$1,973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,973 in reported general payments places this provider in the 45th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$121,361
Medicare patients
430
Services billed
1,353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nucynta ErTapentadol Hcl13$32,784
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen293$10,389
Aimovig AutoinjectorErenumab-Aooe12$8,925
MovantikNaloxegol Oxalate16$6,957
Fentanyl37$3,682
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen135$3,293
Pregabalin91$2,173
Lidocaine17$1,726
Morphine Sulfate ErMorphine Sulfate31$1,517
Oxycodone Hcl49$1,437
Gabapentin125$1,296
Hydromorphone Hcl37$1,187
Tizanidine Hcl64$971
Cyclobenzaprine Hcl50$592
Tramadol Hcl59$387

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er$85$32,78413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 233 pain medicine providers in Illinois.

Other pain medicine in Joliet

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →